Adults 18 and over BMI 24.9 or less: No BMI 25-26.9: Case-by-case** BMI 27-29.9: Likely** BMI 30 or above: Likely Your prescriber will approve or disapprove the GLP-1 prescription at their discretion after careful consideration of your unique health profile
Wegovy is another brand name for semaglutide, approved for weight management at a higher dose (2.4 mg vs 1.0 mg)
When transitioning from Tirzepatide to Retatrutide, the expectation is that the retatrutide dosage schedule after tirzepatide will also follow a once-weekly interval, especially after an appropriate washout period
The number of adults prescribed a GLP-1 without a type 2 diabetes diagnosis jumped nearly 1,961% during the same period (Figure 1)
Depression so often occurs because we disengage from activities that give us life satisfaction, Pagoda says
You do not necessarily need them to prescribe or supervise your treatment, but having someone who can order bloodwork, interpret results, and flag concerns adds a valuable safety layer to year-round use